Conclusions: Primary series vaccination with BNT162b2 and BBIBP-CorV was effective at preventing COVID-19 among HCWs, most of whom had previous infection, during a period of mainly Delta circulation. Our results support the utility of COVID-19 primary vaccine series, a...
Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5-11 years by two-thirds during the Omicron ...
The study found that 60 percent of all adult COVID-19 deaths since June last year could have been prevented with "primary series" vaccination, two doses of Moderna or Pfizer or one dose of the Johnson & Johnson vaccine. The research used data from the U.S. Centers for Disease Control a...
Finally, time-invariant estimates of vaccine protection must be interpreted with caution. These estimates are dependent on the average time since vaccination in the population. Interpretation of protection in this scenario is specific to both the time at which vaccination occurred in the population and...
"Vaccination with a primary series among this age group has lagged behind other age groups, leaving them vulnerable to serious illness," CDC Director Rochelle Walensky said in a statement. "With over 18 million doses administered in this age group, we know that these vaccines are safe, and ...
A primary series of COVID-19 vaccination is recommended for everyone older than 6 months in the United States. Bivalent mRNA vaccines that protect against the original SARS-CoV-2 virus strain and Omicron subvariants are recommended at least 2 months after receiving the primary vaccine series or ...
Association between COVID-19 Booster Vaccination and COVID-19 Outcomes among U.S. Adults Understanding the association between booster vaccination and COVID-19 outcomes can help strengthen post-pandemic messaging and strategies to increase vacc... KH Nguyen,C Mcchesney,R Patel,... 被引量: 0发...
adults aged 60 years and older who completed their primary vaccination series at least 6 months prior were invited to receive a booster injection and given a choice of either 30-μg BNT162b2 (Pfizer-BioNTech) or 50-...
Doses Number: Dose information is reported by date of vaccination. Data is broken-out by the two-dose Pfizer, Moderna, or Novavax primary vaccine series, the one dose Johnson & Johnson primary vaccine series and additional doses of Pfizer, Moderna or Johnson & Johnson. ...
GABORONE, July 6 (Xinhua) -- Botswana is now offering COVID-19 booster shots for children aged between 12 and 17 years, the health ministry has announced. "These children become eligible for booster doses at least six months after completing their primary vaccination series," health ministry ...